AU2003263717A1 - A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES - Google Patents
A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASESInfo
- Publication number
- AU2003263717A1 AU2003263717A1 AU2003263717A AU2003263717A AU2003263717A1 AU 2003263717 A1 AU2003263717 A1 AU 2003263717A1 AU 2003263717 A AU2003263717 A AU 2003263717A AU 2003263717 A AU2003263717 A AU 2003263717A AU 2003263717 A1 AU2003263717 A1 AU 2003263717A1
- Authority
- AU
- Australia
- Prior art keywords
- glucocorticosteroid
- agonist
- treatment
- combination
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202837-1 | 2002-09-25 | ||
SE0202837A SE0202837D0 (en) | 2002-09-25 | 2002-09-25 | New use |
SE0300106-2 | 2003-01-16 | ||
SE0300106A SE0300106D0 (en) | 2003-01-16 | 2003-01-16 | New use |
PCT/SE2003/001486 WO2004028545A1 (en) | 2002-09-25 | 2003-09-24 | A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003263717A1 true AU2003263717A1 (en) | 2004-04-19 |
Family
ID=32044762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003263717A Abandoned AU2003263717A1 (en) | 2002-09-25 | 2003-09-24 | A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003263717A1 (en) |
WO (1) | WO2004028545A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007501194A (en) * | 2003-08-05 | 2007-01-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Inhalable drugs including steroids and beta mimetics |
BRPI0613034A8 (en) | 2005-07-14 | 2018-01-02 | Lipothera Inc | injectable formulation for fat tissue accumulation, injectable formulation and method for treating fat accumulation, and method for reducing fat tissue. |
PL2077830T3 (en) | 2006-10-17 | 2013-04-30 | Lithera Inc | Methods, compositions, and formulations for the treatment of thyroid eye disease |
US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
WO2012007729A2 (en) | 2010-07-16 | 2012-01-19 | Cipla Limited | Pharmaceutical compositions |
WO2012049444A1 (en) | 2010-10-12 | 2012-04-19 | Cipla Limited | Pharmaceutical composition |
CA2815374A1 (en) | 2010-11-24 | 2012-06-07 | Lithera, Inc. | Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
CN102247380A (en) * | 2011-08-19 | 2011-11-23 | 北京阜康仁生物制药科技有限公司 | Compound preparation with budesonide and indacaterol as the active components |
KR20150002774A (en) | 2012-04-11 | 2015-01-07 | 시플라 리미티드 | Pharmaceutical composition comprising arformoterol and fluticasone furoate |
EP3273955A4 (en) | 2015-03-23 | 2019-05-01 | The University of Melbourne | Treatment of respiratory diseases |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5043165A (en) * | 1988-12-14 | 1991-08-27 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs |
WO1990006775A1 (en) * | 1988-12-14 | 1990-06-28 | Liposome Technology, Inc. | A novel nonphospholipid liposome composition for sustained release of drugs |
AU673660C (en) * | 1991-12-18 | 2002-07-25 | Astrazeneca Ab | New combination of formoterol and budesonide |
US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
AU1200097A (en) * | 1995-12-29 | 1997-07-28 | Glaxo Group Limited | 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them |
PL336464A1 (en) * | 1997-03-18 | 2000-06-19 | Basf Ag | Method of and compositions for modulating reactivity in respect to corticosteroids i |
SK184799A3 (en) * | 1997-06-27 | 2000-06-12 | Astra Ab | New combination of antiasthma medicaments |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
JP2003531123A (en) * | 2000-04-13 | 2003-10-21 | イノバータ・バイオミッド・リミテッド | Medicine |
PE20011227A1 (en) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES |
GB0009617D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
KR100787073B1 (en) * | 2000-06-28 | 2007-12-21 | 글리코파이, 인크. | Methods for producing modified glycoproteins |
AR030516A1 (en) * | 2000-08-31 | 2003-08-20 | Glaxo Group Ltd | USE OF A COMBINATION OF SALMETEROL AND FLUTICASONA |
-
2003
- 2003-09-24 WO PCT/SE2003/001486 patent/WO2004028545A1/en not_active Application Discontinuation
- 2003-09-24 AU AU2003263717A patent/AU2003263717A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004028545A1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003279819A1 (en) | Shrimp and the production thereof | |
AU2003272187A1 (en) | Novel nanoparticles and use thereof | |
AU2003214945A1 (en) | Multi-function catheter and use thereof | |
AU2003287671A1 (en) | People lists | |
AU2003216482A1 (en) | MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003286446A1 (en) | Sheet dispensers and methods of making and using the same | |
AU2003243388A1 (en) | Oral irrigation and/or brushing devices and/or methods | |
AU2003288050A1 (en) | Selective stimulation with selective water reduction | |
EP1487033A4 (en) | Battery and method of manufacturing the battery | |
AU2003250497A1 (en) | Creating and conducting a reverse auction | |
AU2003297037A1 (en) | Illuminant and method | |
AU2003295551A1 (en) | Wiping articles and their use | |
AU2003251965A1 (en) | Post-defribillation pacing methods and devices | |
AU2003246083A1 (en) | Ferrocene compound and use thereof | |
AU2003296369A1 (en) | Imminoamines and preparation thereof | |
AU2003263717A1 (en) | A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES | |
AU2003215257A1 (en) | Modified defensins and their use | |
AU2003239610A1 (en) | Tiled biochips and the methods of making the same | |
AU2003298129A1 (en) | Floor-furnace chimney and the use thereof | |
AU2003224956A1 (en) | Reference structures and reference structure enhanced tomography | |
AU2003206945A1 (en) | Use of proteinase inhibitors in the treatment of autoimmune diseases | |
AU2003281691A1 (en) | Furoisoquinoline derivative and use thereof | |
AU2003293939A1 (en) | Polymer-containing pyrrolidone-4-carboxylic acid groups and the use thereof | |
AU2003232785A1 (en) | Novel anthracene derivatives and the use thereof as a medicament | |
AU2003286392A1 (en) | 1microarrays and production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |